Home/ Stocks/ CUE

Cue Biopharma, Inc.

CUE XNAS

$18.73 +1.09 (+6.05%) ▲ 15-min delayed

Open

$18.36

High

$19.00

Low

$17.85

Volume

205.6K

Market Cap

$136.06M

About Cue Biopharma, Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 29 Website →

Related Market News

No specific coverage for CUE yet. Check out our latest market news or earnings calendar.

Get CUE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cue Biopharma, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.